MK-0626

MK-0626 is a selective, orally active DPP-4 inhibitor with an IC50 of 6.3 nM. MK-0626 increases endothelial nitric oxide synthetase expression. MK-0626 improves neovascularization, attenuates hepatic steatosis, attenuates pancreatic islet injury. MK-0626 can be used in the research of diabetes and non-alcoholic fatty liver disease.

For research use only. We do not sell to patients.

  • CAS No.: 690257-74-0
  • Formula: C22H24F2N6O2
  • Molecular Weight:442.46
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Dipeptidyl Peptidase Isoforms

More

All NO Synthase Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00